{"filing":{"accession_number":"0001493152-26-029512","cik":"0000315545","ticker":"PVCT","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/315545/000149315226029512/form8-k.htm"},"events":[{"id":12646,"run_id":11218,"accession_number":"0001493152-26-029512","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses results of an annual meeting of stockholders held on June 18, 2026, with tabulated voting results for five proposals: election of four directors, advisory vote on executive compensation, ratification of auditor selection, authorization for a reverse stock split (1-for-10 to 1-for-50), and authorization to decrease authorized shares. This is a classic Item 5.07 shareholder vote results disclosure, and the reverse stock split authorization is material to investors as it affects share structure and capital allocation.","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","ticker":"PVCT","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":9553,"accession_number":"0001493152-26-029512","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses results of an annual meeting of stockholders held on June 18, 2026, with tabulated voting results for five proposals: election of four directors, advisory vote on executive compensation, ratification of auditor selection, authorization for a reverse stock split (1-for-10 to 1-for-50), and authorization to decrease authorized shares. This is a classic Item 5.07 shareholder vote results disclosure, and the reverse stock split authorization is material to investors as it affects share structure and capital allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T15:29:36.761229+00:00","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","ticker":"PVCT","filing_date":"2026-06-22"}]}